- Home
- VCEL vs BFRGW Comparison
VCEL vs BFRGW Comparison
Compare VCEL & BFRGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- BFRGW
- Stock Information
- Founded
- VCEL 1989
- BFRGW 2017
- Country
- VCEL United States
- BFRGW United States
- Employees
- VCEL N/A
- BFRGW N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- BFRGW Retail: Computer Software & Peripheral Equipment
- Sector
- VCEL Health Care
- BFRGW Technology
- Exchange
- VCEL Nasdaq
- BFRGW Nasdaq
- Market Cap
- VCEL N/A
- BFRGW N/A
- IPO Year
- VCEL 1997
- BFRGW N/A
- Fundamental
- Price
- VCEL $52.00
- BFRGW $0.79
- Analyst Decision
- VCEL Strong Buy
- BFRGW
- Analyst Count
- VCEL 7
- BFRGW 0
- Target Price
- VCEL $63.29
- BFRGW N/A
- AVG Volume (30 Days)
- VCEL 341.7K
- BFRGW 37.4K
- Earning Date
- VCEL 02-27-2025
- BFRGW 03-28-2025
- Dividend Yield
- VCEL N/A
- BFRGW N/A
- EPS Growth
- VCEL N/A
- BFRGW N/A
- EPS
- VCEL 0.07
- BFRGW N/A
- Revenue
- VCEL $226,844,000.00
- BFRGW N/A
- Revenue This Year
- VCEL $23.08
- BFRGW N/A
- Revenue Next Year
- VCEL $21.58
- BFRGW N/A
- P/E Ratio
- VCEL $723.40
- BFRGW N/A
- Revenue Growth
- VCEL 22.48
- BFRGW 550.00
- 52 Week Low
- VCEL $39.12
- BFRGW $1.01
- 52 Week High
- VCEL $63.00
- BFRGW $1.25
- Technical
- Relative Strength Index (RSI)
- VCEL 32.23
- BFRGW N/A
- Support Level
- VCEL $54.45
- BFRGW N/A
- Resistance Level
- VCEL $58.77
- BFRGW N/A
- Average True Range (ATR)
- VCEL 2.25
- BFRGW 0.00
- MACD
- VCEL -0.68
- BFRGW 0.00
- Stochastic Oscillator
- VCEL 1.43
- BFRGW 0.00
About BFRGW Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.